Collective Wisdom: Lobular Carcinoma of the Breast.
暂无分享,去创建一个
[1] D. Dodwell,et al. Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary. , 2016, Clinical radiology.
[2] A. Giobbie-Hurder,et al. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] V. Tjan-Heijnen,et al. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer , 2015, Annals of Surgical Oncology.
[4] M. Lautrup,et al. Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: A single-centre study of 1575 consecutive cases. , 2014, Breast.
[5] A. Turnbull,et al. Molecular changes in lobular breast cancers in response to endocrine therapy. , 2014, Cancer research.
[6] T. King,et al. Magnetic resonance imaging in patients with newly diagnosed breast cancer: A review of the literature , 2014, Cancer.
[7] D. Dabbs,et al. Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response. , 2014, Cancer research.
[8] P. Fasching,et al. Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma , 2014, Breast Cancer Research and Treatment.
[9] R. Turner,et al. Preoperative Magnetic Resonance Imaging in Breast Cancer: Meta-Analysis of Surgical Outcomes , 2013, Annals of surgery.
[10] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[11] H. Putter,et al. Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis. , 2013, European journal of cancer.
[12] D. Berry,et al. Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer , 2012, Breast Cancer Research and Treatment.
[13] J. Carroll,et al. Pioneer factors in hormone-dependent cancers , 2012, Nature Reviews Cancer.
[14] L. Costarelli,et al. Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period , 2012, Annals of Surgical Oncology.
[15] T. Major,et al. Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-Year results. , 2011, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.
[16] J. Dixon,et al. Invasive lobular carcinoma: response to neoadjuvant letrozole therapy , 2011, Breast Cancer Research and Treatment.
[17] M. Beckmann,et al. Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. , 2011, International journal of radiation oncology, biology, physics.
[18] D. Young,et al. Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma , 2009, World journal of surgical oncology.
[19] Ritse M. Mann,et al. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature , 2007, Breast Cancer Research and Treatment.
[20] Michael Gnant,et al. Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF , 2007, Breast Cancer Research and Treatment.
[21] P. Chérel,et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] P. Regitnig,et al. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma , 2006, Journal of Clinical Pathology.
[23] S. Harms,et al. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. , 2005, American journal of surgery.
[24] A. R.,et al. Review of literature , 1960, American Potato Journal.
[25] H. Carmalt,et al. Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. , 2004, Breast.
[26] P. Bult,et al. The Role of MRI in Invasive Lobular Carcinoma , 2004, Breast Cancer Research and Treatment.
[27] R. Rouzier,et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. , 2004, European journal of cancer.
[28] P. Blondeel,et al. Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[29] P. Drew,et al. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[30] T. Lioe,et al. Surgical treatment for invasive lobular carcinoma of the breast. , 2003, Breast.
[31] P. Drew,et al. Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast , 2003 .
[32] M. Wadley,et al. The diagnosis of invasive lobular breast carcinoma. Does MRI have a role? , 2001, Breast.
[33] J. Imbrie,et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. , 2000, Annals of surgery.